Makoto Kaburaki

Initial predictors of poor survival in myositis-associated interstitial lung disease: a multicentre cohort of 497 patients

Shinji Sato, Kenichi Masui, Naoshi Nishina et al. · Lara D. Veeken · 2018 · 159 citations · Full text

Medicine, Immunology, Internal Medicine +17

The growth factor midkine may play a pathophysiological role in rheumatoid arthritis

Shindo Emiko, Toshihiro Nanki, Natsuko Kusunoki et al. · Modern Rheumatology · 2016 · 42 citations · Full text

Medicine, Immunology, Internal Medicine +14

Exacerbation of adult‐onset Still’s disease, possibly related to elevation of serum tumor necrosis factor‐alpha after etanercept administration

Kaichi Kaneko, Makoto Kaburaki, Sei Muraoka et al. · International Journal of Rheumatic Diseases · 2010 · 35 citations

Veterinary Medicine, Immunology, Internal Medicine +14

Pharmacokinetic study and Fcγ receptor gene analysis in two patients with rheumatoid arthritis controlled by low-dose infliximab

Shinichiro Nishio, Tatsuhiro Yamamoto, Kaichi Kaneko et al. · Modern Rheumatology · 2009 · 19 citations

Life Sciences, Immunology, Pharmacology +15

Clinical characteristics of cancer-associated myositis complicated by interstitial lung disease: a large-scale multicentre cohort study

Yuko Kaneko, Takahiro Nunokawa, Yoshinori Taniguchi et al. · Lara D. Veeken · 2019 · 18 citations · Full text

Medicine, Immunology, Internal Medicine +13